Novartis added inclisiran to its pipeline after buying ... In the phase 3 ORION-9, ORION-10 and ORION-11 trials, adding Leqvio to statins achieved LDL-cholesterol reductions of up to 52% versus ...
NHS England said the “game-changing” deal would make a major contribution towards its objective of preventing 150,000 cardiovascular deaths over the next 10 years. If inclisiran were to be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback